Oruka Therapeutics to present at multiple healthcare conferences in November 2026

Oruka Therapeutics, a clinical-stage biotech company focused on treatments for chronic skin diseases like plaque psoriasis, announced it will participate in several upcoming healthcare conferences in November 2026. The company will present at events including the Guggenheim Healthcare Innovation Conference, Stifel Healthcare Conference, UBS Global Biopharma Conference, and Jefferies Global Healthcare Conference. These presentations will highlight Oruka's novel biologics and recent clinical progress, with webcasts available for investors. This exposure aims to boost investor awareness and support for Oruka's mission to improve treatment options for inflammatory skin conditions.

Oruka Therapeutics shares trade at USD 95.51 on Pluang as of Nov 03, 2026 19:15 WIB, showing a slight 0.08% increase in one day. The company holds a market cap of $6.32 billion and a volume of 654,342 shares. Investors typically hold ORKA for about 4 days on the platform, reflecting active interest in this biotech stock.